CBD for Cancer Research: A new advocacy push, Cannabis for Cancer Declaration, is lining up partners for controlled cannabinoid trials in dogs after a 2026 systematic review in Frontiers in Veterinary Science pointed to CBD’s potential antitumor effects across several canine cancers. Medical Cannabis at Work: A University of Georgia study links legal medical marijuana access to fewer health-related sick days—about 6.9% lower absences in states with medical cannabis laws, with the biggest drops in physically demanding jobs. Painkiller Pipeline: Exilby (VER-01), a cannabis-derived, non-opioid oral liquid for chronic low back pain, has FDA Breakthrough Therapy status and is moving through U.S. Phase 3 enrollment. Youth & Vaping Trends: Vermont’s 2025 Youth Risk Behavior Survey shows improving teen mental health alongside lower vaping, alcohol, and marijuana use. Product Safety/Compliance: Ireland’s HSE lab found many vapes and liquids mislabeled or containing semi-synthetic cannabinoids like HHC, plus other concerning substances. Local Cannabis Tensions: San Bernardino residents brought cannabis concerns to City Hall as council weighed community voices around a proposed cannabis business. Regulatory Shock for Hemp Drinks: A new federal THC rule could remove THC-infused beverages from shelves nationwide by November, threatening a major hemp-drink market.